Beijing Luzhu Biotechnology Co., Ltd. provided consolidated earnings guidance for the six months ended June 30, 2023. It is expected that the Group will experience a significant decrease in net loss and a decrease in adjusted net loss for the six months ended June 30, 2023, as compared to the six months ended June 30, 2022. The group expects to record a net loss of not more than RMB 80 million for the six months ended June 30, 2023, representing a decrease of not less than 87% as compared to the net loss of approximately RMB 652 million for the six months ended June 30, 2022.